Gene Therapy Clinical Trials Outcomes

Synthesised 2026-05-16 21:27:54.057987+00:00 · Version 3

As of March 2023, a total of 3,900 gene therapy clinical trials have been completed, ongoing, or approved worldwide. Gene therapy is showing potential as a lasting therapeutic approach for previously untreatable diseases. Successful clinical trial outcomes include various genetic disorders and cancers. Recent advances in gene therapy for Duchenne muscular dystrophy have enabled systemic treatments that affect multiple muscles simultaneously. Current trials are investigating gene delivery methods such as adeno-associated viral vectors and plasmid delivery. Additionally, gene therapies are emerging as new treatment options for non-congenital cardiovascular diseases, which pose significant health risks.

Key facts

• 3,900 gene therapy clinical trials have been completed, ongoing, or approved worldwide as of March 2023. [S0]
• Gene therapy shows potential for lasting therapies for previously untreatable diseases. [S1]
• Successful outcomes span various genetic disorders and cancers, indicating broad efficacy. [S2]
• Advancements in gene therapy for Duchenne muscular dystrophy target multiple muscle systems. [S4]
• Clinical trials explore gene delivery methods like adeno-associated viral vectors. [S5]
• Gene therapies are addressing significant morbidity and mortality in non-congenital cardiovascular diseases. [S6]

Claims

• As of March 2023, there have been a total of 3,900 gene therapy clinical trials completed, ongoing, or approved worldwide.
• Gene therapy has shown potential for providing lasting therapies for previously untreatable diseases.
• Successful outcomes of gene therapy clinical trials span various genetic disorders and cancers.
• Retinal gene therapy clinical trials emphasize the need for effective measurement of trial outcomes to evaluate treatment efficacy.
• Recent advances in gene therapy for Duchenne muscular dystrophy have led to systemic treatments targeting multiple muscles.
• Clinical trials for muscular dystrophies explore gene delivery methods like adeno-associated viral vectors and plasmid delivery.
• Gene therapies present a new treatment option for non-congenital cardiovascular diseases, addressing significant morbidity and mortality.

Bibliography (5)

1. Gene therapy clinical trials worldwide to 2023-an update - PubMed
2. Clinical development of gene therapy: results and lessons from ...
3. Current Status of Clinical Trials Design and Outcomes in Retinal Gene Therapy.
4. Gene Therapy Clinical Trials for Muscular Dystrophies
5. Characteristics and Outcomes of Clinical Trials on Gene Therapy in Noncongenital Cardiovascular Diseases: Cross-sectional Study of Three Clinical Trial Registries (Preprint)

← Sourcipedia